PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9369952-6	1997	A PKC inhibitor, staurosporine (5 microM) likewise inhibited the BK-induced increase in endothelial cell permeability to albumin.	Staurosporine	17-30	kininogen 1	Bos taurus	65-67	
8220902-9	1993	Exposure of AG04762 cells for 10 min to staurosporine produced a concentration-dependent inhibition (IC50 = 107 +/- 14 nM) in bradykinin-stimulated prostacyclin release.	Staurosporine	40-53	kininogen 1	Bos taurus	126-136	
8433044-8	1993	In contrast, bradykinin- or ATP-induced phosphorus 32-labeled PA and [32P]-labeled PEt formation was only partially blocked (70% inhibition) by either staurosporine (10 mumol/L) or PKC down-regulation, suggesting that part of agonist-stimulated PLD activity may occur in the absence of PKC activation.	Staurosporine	151-164	kininogen 1	Bos taurus	13-23	
1446322-7	1992	In contrast, staurosporine (a putative inhibitor of protein kinase C) substantially inhibited the U46619 and bradykinin dependent release of 6-oxo-PGF1 alpha.	Staurosporine	13-26	kininogen 1	Bos taurus	109-119	
1665733-8	1991	Furthermore, staurosporine (100 nM) increased [Ca2+]i when added during the plateau phase of the increase in [Ca2+]i induced by thrombin or bradykinin.	Staurosporine	13-26	kininogen 1	Bos taurus	140-150